Fingerprint
Dive into the research topics of 'Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy
Leendert van Steensel, Dion Paridaens, Benjamin Schrijver, Gemma M Dingjan, Paul L A van Daele, P Martin van Hagen, Willem A van den Bosch, Hemmo A Drexhage, Herbert Hooijkaas, Willem A Dik
Research output: Contribution to journal › Article › Research › peer-review